If you enjoy this content, please share it with a colleague
RELATED CONTENT
Advances in digital mammography are evolving as clinicians look to improve breast cancer screening in women. In recent years, new technological trends have emerged; notably, the addition of 3-D breast imaging, or tomosynthesis, which was approved by the U.S. Food and Drug Administration (FDA) in 2011. But as technology improves, questions remain over the recommended frequency of screening for breast cancer.
The Radiological Society of North America (RSNA) annual meeting has transitioned in recent years from an imaging device focus to an imaging information technology focus. The interest in software continued at this year’s meeting, partly fueled by the need for healthcare organizations to meet Stage 1 and 2 meaningful use requirements. Two key trends seen throughout the show floor included remote viewing systems for radiology images and technology streamlined to aid workflow efficiency.
March 13, 2012 – Fischer Medical Technologies LLC (Fisher Medical), announces from the National Interdisciplinary Breast Center Conference that it has been named exclusive U.S. distributor of GIOTTO’s Full Field Digital Mammography (FFDM) systems.
Giotto USA yesterday announced clearance by the U.S. Food and Drug Administration (FDA) of a 510(k) application for the Giotto Image 3D and 3DL digital mammography systems. The systems, the 3D with an 18 by 24 cm bucky and the 3DL with a 24 by 30 cm bucky, may now be marketed in the U.S.